Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe

Journal of Chromatographic Science

Volumn 51, Issue 3, 2013, Pages 222-228

  Goel, Amit ^a   Baboota, Sanjula ^a   Sahni, Jasjeet K ^a   Srinivas, Kona S ^b   Gupta, Ravi S ^b   Gupta, Abhishek ^b   Semwal, Vinod P ^b   Ali, Javed ^a  

^a HAMDARD UNIVERSITY   (India)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; AZETIDINE DERIVATIVE; EZETIMIBE; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE;

ARTICLE; CHEMISTRY; DRUG COMBINATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TABLET;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; DRUG STABILITY; HEPTANOIC ACIDS; PYRROLES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TABLETS;

EID: 84873285598     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bms131     Document Type: Article

References (37)

1. Lipitorw (Atorvastatin calcium): Drug Information. Rx List: The Internet Drug Index. http://www.rxlist.com/cgi/generic/atorvastatin.html (accessed June 13, 2011).
2. Zetiaw (Ezetimibe Tablets): Drug Information. Rx List: The Internet Drug Index. http://www.rxlist.com/cgi/generic/ezetimibe.html (accessed June 13, 2011).
3. Melani, L., Mills, R., Hassman, D.; Efficacy and safety of ezetimibe co-administered with pravastatin in patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial; European Heart Journal, (2003); 24: 717-728.
4. Kadav, A.A., Vora, D.N.; Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets; Journal of Pharmaceutical and Biomedical Analysis, (2008); 48: 120-126.
5. Novakova, L., Vickova, H., Satinsky, D., Sadilek, P., Solichova, D., Blaha, M.; Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of simvastatin and atorvastatin; Journal of Chromatography B, (2009); 877: 2093-2103.
6. Seshadri, R., Desai, M.M., Raghavaraja, T.V., Krishnan, D., Rao, D., Chakravarthy, I.E.; Simultaneous quantitative determination of metoprolol, atorvastatin and ramipril in capsules by a validated stability-indicating RP-UPLC method; Pharmabiz, (2010); 78: 821-834.
7. Shah, Y., Iqbal, Z., Ahmad, L., Khan, A., Khan, M.I., Nazir, S.; Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC; Journal of Chromatography B, (2011); 879: 557-563.
8. Sivakumar, T., Manavalan, R., Muralidharan, C., Valliapan, K.; An improved HPLC method with the aid of a chemometric protocol: Simultaneous analysis of amlodipine and atorvastatin in pharmaceutical formulation; Journal of Separation Science, (2007); 30: 3143-3153.
9. Mustafa, G., Azeem, A., Ahmad, F.J., Khan, Z.I., Shakeel, F., Talegaonkar, S.; Stability-indicating RP-HPLC method for analysis of atorvastatin in bulk drug, marketed tablet and nanoemulsion formulation; Journal of Chilean Chemical Society, (2010); 55: 184-188.
10. Novakova, L., Satinsky, D.; HPLC methods for the determination of simvastatin and atorvastatin; Trends in Analytical Chemistry, (2008); 27: 352-367.
11. Erturk, S., Aktas, E.S., Ersoy, L.; A HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets; Journal of Pharmaceutical and Biomedical Analysis, (2003); 33: 1017-1023.
12. Rajeshwari, K.R., Sakar, G.G., Rao, A.L.; RP-HPLC method for the simultaneous determination of atorvastatin and amlodipine in tablet dosage form; Indian Journal of Pharmaceutical Sciences, (2006); 68: 275-277.
13. Vuletic, M., Cindric, M., Kouznjak, J.D.; Identification of unknown impurities of atorvastatin calcium substances and tablets by liquid chromatography/tandem mass spectrometry; Journal of Pharmaceutical and Biomedical Analysis, (2005); 37: 715-717.
14. Nakarani, N.V., Bhatt, K.K., Patel, R.D., Bhatt, H.S.; Estimation of atorvastatin calcium and fenofibrate in tablets by derivative spectrophotometry; The Journal of AOAC International, (2007); 90: 700-705.
15. Mazurek, S., Szostak, R; Quantification of atorvastatin calcium in tablets by FT-Raman spectroscopy; Journal of Pharmaceutical and Biomedical Analysis, (2009); 49: 168-172.
16. Wang, L., Asgharnejad, M.; Second derivative UV spectrometric determination of atorvastatin calcium in tablet dosage form; Journal of Pharmaceutical and Biomedical Analysis, (2000); 21: 1243-1248.
17. Patole, S.M., Khodke, A.S., Patole, L.V., Damle, M.C.; A validated HPTLC method for analysis of atorvastatin calcium and metoprolol as bulk drugs and in combined capsule dosage forms; Journal of Young Pharmacists, (2011); 3: 55-59.
18. Patil, U.P., Gandhi, S.V., Sengar, M.R., Rajmane, V.S.; A validated densitometric method for analysis of telmisartan and atorvastatin calcium in fixed dose combination; Journal of Chilean Chemical Society, (2010); 55: 94-96.
19. Morris, M.J., Gilbert, J.D., Hsieh, J.Y.; Determination of the HMG-CoA reductase inhibitors atorvastatin calcium, lovastatin and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry; Biological Mass Spectrometry, (1993); 22: 1-8.
20. Lofty, H.M., Hegazy, M.A.; Quantitative analysis of ezetimibe and simvastatin in pure powder, binary mixtures and a combined dosage form by spectrophotometry, cemometry and HPLC; The Journal of AOAC International, (2010); 93: 1844-1855.
21. Maher, H.M., Youssef, R.M., Hassan, E.M., Barary, M.A.; Enhanced pectrophotometric determination of two antihyperlipidemic mixtures containing ezetimibe in pharmaceutical preparations; Drug Testing and Analysis, (2011); 3: 97-105.
22. Rajput, S.J., Rajput, H.A.; Simultaneous spectroscopic estimation of ezetimibe and simvastatin in tablet dosage forms; Indian Journal of Pharmaceutical Sciences, (2007); 69: 683-684.
23. Imran, M., Singh, R.S., Chandran, S.; Stability indicating ultraviolet spectroscopic method for the estimation of ezetimibe and carvedilol; Pharmabiz, (2006); 61: 766-769.
24. Singh, S., Singh, B., Bahuguna, R., Wadhwa, L., Saxena, R.; Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assay; Journal of Pharmaceutical and Biomedical Analysis, (2006); 41: 1037-1040.
25. Sistla, R., Tata, V.S.S.K, Kashyap, Y.V., Chandrasekhar, D., Diwan, P.V.; development and validation of a RP- HPLC method for the determination of ezetimibe in pharmaceutical dosage forms; Journal of Pharmaceutical and Biomedical Analysis, (2005); 39: 517-522.
26. Dixit, R.P., Barhate, C.R., Padhye, S.G., Viswanathan, C.L., Nagarsenker, M.S.; Stability indicating RP-HPLC method for simultaneous determination of simvastatin and ezetimibe from tablet dosage form; Indian Journal of Pharmaceutical Sciences, (2010); 72: 204-210.
27. Jafar, S., Basha, S.; Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection; Journal of Chromatography B, (2007); 853: 88-96.
28. Ostwald, S., Scheuch, E., Cascorbid, I., Siegmund, W.; A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCOB1; Journal of Chromatography B, (2006); 830: 143-150.
29. Varghese, S.J., Ravi, T.K.; Determination of rosuvastatin and ezetimibe in a combined tablet dosage form using HPTLC and HPLC; The Journal of AOAC International, (2010); 93: 1222-1227.
30. Chaudhari, B.G.; Stability indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products; The Journal of AOAC International, (2007); 90: 1539-1546.
31. Bhatt, L., Kumar, R.; Simultaneous estimation of atorvastatin calcium and ezetimibe in tablet by RP-HPLC method; International Journal of Pharmaceutical and Applied Sciences, (2010); 11: 114-117.
32. Sama, J.R., Kalakuntla, R.R., Rao, V.S.N., Reddanna, P.; Simultaneous estimation of atorvastatin and ezetimibe in pharmaceutical formulations by RP-HPLC method; Scholars Research Library, (2010); 2: 427-436.
33. Chaudhari, B.G., Patel, N.M., Shah, P.B., Modi, K.P.; Development and validation of a HPTLC method for the simultaneous estimation of atorvastatin calcium and ezetimibe; Indian Journal of Pharmaceutical Sciences, (2006); 68: 793-796.
34. Rajamanickam, V., Rathinaraj, B.S., Jesupillai, M.; Determination of atorvastatin calcium and ezetimibe by using HPTLC method; International Journal of Preclinical and Pharmaceutical Research, (2010); 1: 39-43.
35. Sonawane, S.S., Shirkhedkar, A.A., Fursule, R.A., Surana, S.J.; Simultaneous spectrophotometric estimation of atorvastatin calcium and ezetimibe in tablets; Indian Journal of Pharmaceutical Sciences, (2007); 69: 683-684.
36. International Conference on Harmonization (ICH); Q2 (R1), Validation of analytical procedures: Text and methodology. Geneva, Switzerland, (2005).
37. Bakshi, M., Singh, S.; Development of validated stability-indicating assay methods-Critical review; Journal of Pharmaceutical and Biomedical Analysis, (2002); 28: 1011-1040.